Credit Suisse Raises Price Target on Aetna (AET)

Credit Suisse reported on Wednesday that it has raised its price target on health benefits company, Aetna Inc. (AET).

The firm, which currently has a “Neutral” rating on the AET, has increased the company’s price target to $65. This price target suggests 8% upside from the stock’s current price of $59.44.

Analysts have also raised estimates on the company through 2014 as the acquisition of Coventry Health is expected to improve earnings.

Aetna shares were mostly flat during Wednesday morning trading. The stock is up 28% YTD.

The Bottom Line
Shares of Aetna Inc. (AET) have a 1.34% yield, based on Wednesday’s closing price of $59.55.

Aetna Inc. (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here